Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia

被引:132
|
作者
Prina, Elena [1 ,2 ]
Ranzani, Otavio T. [1 ,2 ]
Polverino, Eva [1 ,3 ]
Cilloniz, Catia [1 ,3 ]
Ferrer, Miquel [1 ,3 ]
Fernandez, Laia [1 ,3 ]
Puig de la Bellacasa, Jorge [4 ]
Menendez, Rosario [3 ,5 ]
Mensa, Josep [6 ]
Torres, Antoni [1 ,3 ]
机构
[1] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Torax, Barcelona, Spain
[2] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst, Sao Paulo, Brazil
[3] Ctr Invest Biomed Red Enfermedades Resp, Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain
[5] Hosp Univ La Fe, Serv Neumol, Valencia, Spain
[6] Hosp Clin Barcelona, IDIBAPS, Serv Enfermedades Infecciosas, Barcelona, Spain
关键词
community-acquired pneumonia; antibiotic therapy; infection; CARE-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA; HOSPITALIZED-PATIENTS; GUIDELINES; DISEASES; SOCIETY; MULTICENTER; INFECTIONS; MANAGEMENT;
D O I
10.1513/AnnalsATS.201407-305OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: To identify pathogens that require different treatments in community-acquired pneumonia (CAP), we propose an acronym, "PES" (Pseudomonas aeruginosa, Enterobacteriaceae extended-spectrum beta-lactamase-positive, and methicillin-resistant Staphylococcus aureus). Objectives: To compare the clinical characteristics and outcomes between patients with CAP caused by PES versus other pathogens, and to identify the risk factors associated with infection caused by PES. Methods: We conducted an observational prospective study evaluating only immunocompetent patients with CAP and an established etiological diagnosis. We included patients from nursing homes. We computed a score to identify patients at risk of PES pathogens. Measurement and Main Results: Of the 4,549 patients evaluated, we analyzed 1,597 who presented an etiological diagnosis. Pneumonia caused by PES was identified in 94 (6%) patients, with 108 PES pathogens isolated (n = 72 P. aeruginosa, n = 15 Enterobacteriaceae extended-spectrum beta-lactamase positive, and n = 21 methicillin-resistant Staphylococcus aureus). These patients were older (P = 0.001), had received prior antibiotic treatment more frequently (P < 0.001), and frequently presented with acute renal failure (P = 0.004). PES pathogens were independently associated with increased risk of 30-day mortality (adjusted odds ratio = 2.51; 95% confidence interval = 1.20-5.25; P = 0.015). The area under the curve for the score we computed was 0.759 (95% confidence interval, 0.713-0.806; P < 0.001). Conclusions: PES pathogens are responsible for a small proportion of CAP, resulting in high mortality. These pathogens require a different antibiotic treatment, and identification of specific risk factors could help to identify these microbial etiologies.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 50 条
  • [1] Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis
    Torres, Antoni
    Cilloniz, Catia
    Ferrer, Miguel
    Gabarrus, Albert
    Polverino, Eva
    Villegas, Santiago
    Marco, Francesc
    Mensa, Josep
    Menendez, Rosario
    Niederman, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1353 - 1363
  • [2] Antibiotic-Resistant Community-Acquired Bacterial Pneumonia
    Ho, Jeffery
    Ip, Margaret
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (04) : 1087 - +
  • [3] Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia
    Shindo, Yuichiro
    Ito, Ryota
    Kobayashi, Daisuke
    Ando, Masahiko
    Ichikawa, Motoshi
    Shiraki, Akira
    Goto, Yasuhiro
    Fukui, Yasutaka
    Iwaki, Mai
    Okumura, Junya
    Yamaguchi, Ikuo
    Yagi, Tetsuya
    Tanikawa, Yoshimasa
    Sugino, Yasuteru
    Shindoh, Joe
    Ogasawara, Tomohiko
    Nomura, Fumio
    Saka, Hideo
    Yamamoto, Masashi
    Taniguchi, Hiroyuki
    Suzuki, Ryujiro
    Saito, Hiroshi
    Kawamura, Takashi
    Hasegawa, Yoshinori
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) : 985 - 995
  • [4] Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia
    Campana-Duel, E.
    Camprubi-Rimblas, M.
    Areny-Balaguero, A.
    Quero, Sara
    Artigas, A.
    Ceccato, A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (02) : 246 - 254
  • [5] Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia
    Sibila, Oriol
    Laserna, Elena
    Maselli, Diego Jose
    Fernandez, Juan Felipe
    Mortensen, Eric M.
    Anzueto, Antonio
    Waterer, Grant
    Restrepo, Marcos I.
    RESPIROLOGY, 2015, 20 (04) : 660 - 666
  • [6] Community-Acquired Pneumonia with Risk for Drug-Resistant Pathogens
    Fleming, Virginia
    Buck, Brian
    Nix, Nancy
    Kumar, Parag
    Southwood, Robin
    SOUTHERN MEDICAL JOURNAL, 2013, 106 (03) : 209 - 216
  • [7] Potential antibiotic resistant pathogens in community-acquired pneumonia: playing it safe is anything but
    Waterer, Grant W.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [8] Antibiotic Resistance in Community-Acquired Pneumonia Pathogens
    Wunderink, Richard G.
    Yin, Yudong
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (06) : 829 - 838
  • [9] Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
    Amati, Francesco
    Bindo, Francesco
    Stainer, Anna
    Gramegna, Andrea
    Mantero, Marco
    Nigro, Mattia
    Bussini, Linda
    Bartoletti, Michele
    Blasi, Francesco
    Aliberti, Stefano
    ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (03) : 224 - 238
  • [10] Strategies for prediction of drug-resistant pathogens and empiric antibiotic selection in community-acquired pneumonia
    Gil, Ryan
    Webb, Brandon J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (03) : 249 - 259